Mitochondrial tyrosine phosphoproteome: New insights from an up-to-date analysis

BioFactors

Volumn 36, Issue 6, 2010, Pages 437-450

  Cesaro, Luca ^a   Salvi, Mauro ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Electron transport chain; Mitochondria; Mitochondrial carriers; Mitochondrial permeability transition pore; Tyrosine phosphoproteome; VDAC

Indexed keywords

ACETYL COENZYME A ACETYLTRANSFERASE; ADENYLATE KINASE; ALDEHYDE DEHYDROGENASE; GLUTAMATE DEHYDROGENASE; HYDROXYACYLGLUTATHIONE HYDROLASE; MALATE DEHYDROGENASE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOCHONDRIAL PROTEIN; PHOSPHOTYROSINE; PYRUVATE DEHYDROGENASE; SERINE PROTEINASE OMI; VOLTAGE DEPENDENT ANION CHANNEL 1;

AMINO ACID METABOLISM; APOPTOSIS; ARTICLE; CITRIC ACID CYCLE; CLINICAL ASSESSMENT; COMPUTER MODEL; FATTY ACID METABOLISM; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS REGULATION; PROTEIN TRANSPORT; RESPIRATORY CHAIN;

HUMANS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MODELS, MOLECULAR; PHOSPHOPROTEINS; PHOSPHORYLATION; PHOSPHOTRANSFERASES; PROTEOME; TYROSINE;

EID: 78650120951     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.123     Document Type: Article

References (52)

1. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., and Sudarsanam, S. ( 2002) The protein kinase complement of the human genome. Science 298, 1912-1934.
2. Cohen, P. ( 2002) Protein kinases-the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 1, 309-315.
3. Johnson, L. N. ( 2009) Protein kinase inhibitors: contributions from structure to clinical compounds. Q. Rev. Biophys. 42, 1-40.
4. Pagliarini, D. J. and Dixon, J. E. ( 2006) Mitochondrial modulation: reversible phosphorylation takes center stage? Trends Biochem. Sci. 31, 26-34.
5. Salvi, M., Brunati, A. M., and Toninello, A. ( 2005) Tyrosine phosphorylation in mitochondria: a new frontier in mitochondrial signalling. Free Radic. Biol. Med. 38, 1267-1277.
6. Rush, J., Moritz, A., Lee, K. A., Guo, A., Goss, V. L., Spek, E. J., Zhang, H., Zha, X. M., Polakiewicz, R. D., and Comb, M. J. ( 2005) Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 23, 94-101.
7. Diella, F., Gould, C. M., Chica, C., Via, A., and Gibson, T. J. ( 2008) Phospho.ELM: a database of phosphorylation sites-update 2008. Nucleic Acids Res. 36, D240-D244.
8. Hornbeck, P. V., Chabra, I., Kornhauser, J. M., Skrzypek, E., and Zhang, B. ( 2004) PhosphoSite: a bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics 4, 1551-1561.
9. Salvi, M., Cesaro, L., and Pinna, L. A. ( 2010) Variable contribution of protein kinases to the generation of the human phosphoproteome: a global weblogo analysis. Biomol. Concepts 1, 185-195.
10. Toppo, S., Pinna, L. A., and Salvi, M. ( 2010) Matching up phosphosites to kinases: a survey of the available predictive programs. Curr. Bioinform. 5, 141-152.
11. Miyazaki, T., Neff, L., Tanaka, S., Horne, W. C., and Baron, R. ( 2003) Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. J. Cell. Biol. 160, 709-718.
12. Livigni, A., Scorziello, A., Agnese, S., Adornetto, A., Carlucci, A., Garbi, C., Castaldo, L., Annunziato, L., Avvedimento, E. V., and Feliciello, A. ( 2006) Mitochondrial AKAP121 links cAMP and src signaling to oxidative metabolism. Mol. Biol. Cell. 17, 263-271.
13. Lee, I., Salomon, A. R., Ficarro, S., Mathes, I., Lottspeich, F., Grossman, L. I., and Hüttemann, M. ( 2005) cAMP-dependent tyrosine phosphorylation of subunit I inhibits cytochrome c oxidase activity. J. Biol. Chem. 280, 6094-6100.
14. Samavati, L., Lee, I., Mathes, I., Lottspeich, F., and Hüttemann, M. ( 2008) Tumor necrosis factor alpha inhibits oxidative phosphorylation through tyrosine phosphorylation at subunit I of cytochrome c oxidase. J. Biol. Chem. 283, 21134-21144.
15. Demory, M. L., Boerner, J. L., Davidson, R., Faust, W., Miyake, T., Lee, I., Hüttemann, M., Douglas, R., Haddad, G., and Parsons, S. J. ( 2009) Epidermal growth factor receptor translocation to the mitochondria: regulation and effect. J. Biol. Chem. 284, 36592-36604.
16. Augereau, O., Claverol, S., Boudes, N., Basurko, M. J., Bonneu, M., Rossignol, R., Mazat, J. P., Letellier, T., and Dachary-Prigent, J. ( 2005) Identification of tyrosine-phosphorylated proteins of the mitochondrial oxidative phosphorylation machinery. Cell. Mol. Life Sci. 62, 1478-1488.
17. Salvi, M., Morrice, N., Brunati, A. M., and Toninello, A. ( 2007) Identification of the flavoprotein of succinate dehydrogenase and aconitase as in vitro mitochondrial substrates of Fgr tyrosine kinase. FEBS Lett. 581, 5579-5585.
18. Yu, H., Lee, I., Salomon, A. R., Yu, K., and Hüttemann, M. ( 2008) Mammalian liver cytochrome c is tyrosine-48 phosphorylated in vivo, inhibiting mitochondrial respiration. Biochim. Biophys. Acta 1777, 1066-1071.
19. Di Pancrazio, F., Bisetto, E., Alverdi, V., Mavelli, I., Esposito, G., and Lippe, G. ( 2006) Differential steady-state tyrosine phosphorylation of two oligomeric forms of mitochondrial F0F1ATPsynthase: a structural proteomic analysis. Proteomics 6, 921-926.
20. Lewandrowski, U., Sickmann, A., Cesaro, L., Brunati, A. M., Toninello, A., and Salvi, M. ( 2008) Identification of new tyrosine phosphorylated proteins in rat brain mitochondria. FEBS Lett. 582, 1104-1110.
21. Feng, J., Zhu, M., Schaub, M. C., Gehrig, P., Roschitzki, B., Lucchinetti, E., and Zaugg, M. ( 2008) Phosphoproteome analysis of isoflurane-protected heart mitochondria: phosphorylation of adenine nucleotide translocator-1 on Tyr194 regulates mitochondrial function. Cardiovasc Res. 80, 20-29.
22. Lewandrowski, U., Tibaldi, E., Cesaro, L., Brunati, A. M., Toninello, A., Sickmann, A., and Salvi, M. ( 2009) Analysis of tyrosine-phosphorylated proteins in rat brain mitochondria. Methods Enzymol. 457, 117-136.
23. Feng, J., Lucchinetti, E., Enkavi, G., Wang, Y., Gehrig, P., Roschitzki, B., Schaub, M. C., Tajkhorshid, E., Zaugg, K., and Zaugg, M. ( 2010) Tyrosine phosphorylation by Src within the cavity of the adenine nucleotide translocase 1 regulates ADP/ATP exchange in mitochondria. Am. J. Physiol. Cell Physiol. 298, C740-C748.
24. Pebay-Peyroula, E., Dahout-Gonzalez, C., Kah, R., Trezeguet, V., Lauquin, G. J. M. and Brandolin, G. ( 2003) Structure of mitochondrial ADP/ATP carrier in complex with carboxyactractyloside. Nature 426, 39-44.
25. Palmieri, F. ( 2004) The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflugers Arch. 447, 689-709.
26. Ujwal, R., Cascio, D., Colletier, J. P., Faham, S., Zhang, J., Toro, L., Ping, P., and Abramson, J. ( 2008) The crystal structure of mouse VDAC1 at 2.3. A resolution reveals mechanistic insights into metabolite gating. Proc. Natl. Acad. Sci. USA 105, 17742-17747.
27. Bayrhuber, M., Meins, T., Habeck, M., Becker, S., Giller, K., Villinger, S., Vonrhein, C., Griesinger, C., Zweckstetter, M., and Zeth, K. ( 2008) Structure of the human voltage-dependent anion channel. Proc. Natl. Acad. Sci. USA 105, 15370-15375.
28. Hiller, S., Garces, R. G., Malia, T. J., Orekhov, V. Y., Colombini, M., and Wagner, G. ( 2008) Solution structure of the integral human membrane protein VDAC1 in detergent micelles. Science 32, 1206-1210.
29. De Pinto, V., Reina, S., Guarino, F., and Messina, A. ( 2008) Structure of the voltage dependent anion channel: state of the art. J. Bioenerg. Biomembr. 40, 139-147.
30. Chen, Y., Craigen, W. J., and Riley, D. J. ( 2009) Nek1 regulates cell death and mitochondrial membrane permeability through phosphorylation of VDAC1. Cell Cycle 8, 257-267.
31. Chen, Y., Gaczynska, M., Osmulski, P., Polci, R., and Riley, D. J. ( 2010) Phosphorylation by Nek1 regulates opening and closing of voltage dependent anion channel 1. Biochem. Biophys. Res. Commun 394, 798-803.
32. Jimenez, J. L., Hegemann, B., Hutchins, J. R. A., Peters, J. M., and Durbin, R. ( 2007) A systematic comparative and structural analysis of protein phosphorylation sites based on the mtcPTM database. Genome Biol. 8, R90.
33. Smith, T. J. and Stanley, C. A. ( 2008) Untangling the glutamate dehydrogenase allosteric nightmare. Trends Biochem. Sci. 33, 557-564.
34. Smith, T. J., Schmidt, T., Fang, J., Wu, J., Siuzdak, G., and Stanley, C. A. ( 2002) The structure of apo human glutamate dehydrogenase details subunit communication and allostery. J. Mol. Biol. 318, 765-777.
35. O'Brien, T. W. ( 2003) Properties of human mitochondrial ribosomes. IUBMB life 55, 505-513.
36. Miller, J. L., Cimen, H., Koc, H., and Koc, E. C. ( 2009) Phosphorylated proteins of the mammalian mitochondrial ribosome: implications in protein synthesis. J. Proteome Res. 8, 4789-4798.
37. Tatsuta, T. and Langer T. ( 2008) Quality control of mitochondria: protection against neurodegeneration and ageing. EMBO J. 27, 306-314.
38. Martinelli, P. and Rugarli, E. I. ( 2010) Emerging roles of mitochondrial proteases in neurodegeneration. Biochim. Biophys. Acta 1797, 1-10.
39. Li, W., Srinivasula, S. M., Chai, J., Li, P., Wu, J. W., Zhang, Z., Alnemri, E. S., and Shi, Y. ( 2002) Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi, Nat. Struct. Biol. 9, 436-441.
40. Vande Walle, L., Lamkanfi, M., and Vandenabeele, P. ( 2008) The mitochondrial serine protease HtrA2/Omi: an overview. Cell Death Differ. 15, 453-460.
41. Rikova, K, et al. ( 2007) Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131, 1190-1203.
42. Zhang, Y., Appleton, B. A., Wu, P., Wiesmann, C., and Sidhu, S. S. ( 2007) Structural and functional analysis of the ligand specificity of the HtrA2/Omi PDZ domain. Protein Sci. 16, 1738-1750.
43. Hartkamp, J., Carpenter, B., and Roberts, S. G. ( 2010) The Wilms' tumor suppressor protein WT1 is processed by the serine protease HtrA2/Omi. Mol. Cell. 37, 159-171.
44. Bernardi, P. and Forte, M. ( 2007) The mitochondrial permeability transition pore. Novartis Found Symp. 287, 157-164.
45. Di Lisa, F. and Bernardi, P. ( 2009) A CaPful of mechanisms regulating the mitochondrial permeability transition. J. Mol. Cell Cardiol. 46, 775-780.
46. Zorov, D. B., Juhaszova, M., Yaniv, Y., Nuss, H. B., Wang, S., and Sollott, S. J. ( 2009) Regulation and pharmacology of the mitochondrial permeability transition pore. Cardiovasc. Res. 15, 213-225.
47. Zoratti, M., Szabò, I., and De Marchi, U. ( 2005) Mitochondrial permeability transitions: how many doors to the house? Biochim. Biophys. Acta 1706, 40-52.
48. Toninello, A., Salvi, M., Schweizer, M., and Richter, C. ( 2004) Menadione induces a low conductance state of the mitochondrial inner membrane sensitive to bongkrekic acid. Free Radic. Biol. Med. 37, 1073-1080.
49. Leung, A. W. C., Varanyuwatana, P., and Halestrap, A. P. ( 2008) The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition. J. Biol. Chem. 283, 26312-26323.
50. Hartmann, J. T., Haap, M., Kopp, H. G., and Lipp, H. P. ( 2009) Tyrosine kinase inhibitors-a review on pharmacology, metabolism and side effects. Curr. Drug Metab. 10, 470-481.
51. Salvi, M., Brunati, A. M., La Rocca, N., Bordin, L., Clari, G., and Toninello, A. ( 2002) Characterization and location of Src-dependent Tyrosine phosphorylation in rat brain mitochondria. Biochim. Biophys. Acta 1589, 181-195.
52. Gringeri, E., Carraro, A., Tibaldi, E., D'Amico, F. E., Mancon, M., Toninello, A., Pagano, M. A, Vio, C., Cillo, U., and Brunati, A. M. ( 2009) Lyn-mediated mitochondrial tyrosine phosphorylation is required to preserve mitochondrial integrity in early liver regeneration. Biochem J. 425, 401-412.